Mirum Pharmaceuticals Inc (NASDAQ:MIRM)
| 32.82 Delayed Data As of Dec 08 |  +0.54 / +1.67%Today’s Change | 17.49 Today|||52-Week Range 33.39 | +68.31% Year-to-Date |
Latest MIRM News | Press Releases
No recent news for Mirum Pharmaceuticals Inc.
Today’s Trading
| Previous close | 32.28 |
| Today’s open | 32.49 |
| Day’s range | 32.40 - 33.06 |
| Volume | 21,632 |
| Average volume (3 months) | 510,394 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -44.74% |
| Earnings growth (this year) | +38.65% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +302.66% |
| P/E ratio | NM |
| Price/Sales | 8.56 |
| Price/Book | 8.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SMMTSummit Therapeutics ... | -0.04 | -1.80% |
| AMRXAmneal Pharmaceutica... | +0.37 | +7.89% |
| CPRXCatalyst Pharmaceuti... | -0.17 | -1.19% |
| ---- |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 6, 2024 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $77.1M |
| Annual profit (last year) | -$135.7M |
| Net profit margin | -176.05% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
